The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126280431 12628043 1 I 20121008 20160807 20160807 EXP PHHY2012CN089507 NOVARTIS LOU Y, ZHNAG P, SHANG Y, LOU SF, ZHOU K, CHEN S AND ET AL.. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOLLOWED BY SEQUENTIAL INFUSION OF DONOR-DERIVED CYTOKINE INDUCED KILLER CELLS FOR RELAPSED/REFRACTORY HEMATOLOGIC MALIGNANCY: A PRELIMINARY STUDY OF 9 CASES. TUMOR. 2012;32(7):546-50 48.00 YR M Y 0.00000 20160808 OT CN CN

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126280431 12628043 1 PS NEORAL CYCLOSPORINE 1 Intravenous (not otherwise specified) 2.5 MG/KG, QD U 50715 2.5 MG/KG QD
126280431 12628043 2 SS NEORAL CYCLOSPORINE 1 Oral 5 MG/KG, UNK U 50715 5 MG/KG
126280431 12628043 3 SS NEORAL CYCLOSPORINE 1 U 50715
126280431 12628043 4 SS SIMULECT BASILIXIMAB 1 Unknown 20 MG, ONCE/SINGLE U 0 20 MG 1X
126280431 12628043 5 SS SIMULECT BASILIXIMAB 1 U 0
126280431 12628043 6 SS SIMULECT BASILIXIMAB 1 U 0
126280431 12628043 7 SS METHOTREXATE. METHOTREXATE 1 Intravenous (not otherwise specified) 15 MG/M2, ONCE/SINGLE ON DAY +1 U 0 15 MG/M**2 CONCENTRATE FOR SOLUTION FOR INJECTION 1X
126280431 12628043 8 SS METHOTREXATE. METHOTREXATE 1 Intravenous (not otherwise specified) 10 MG/M2, ONCE/SINGLE ON DAY +3 U 0 10 MG/M**2 CONCENTRATE FOR SOLUTION FOR INJECTION 1X
126280431 12628043 9 SS METHOTREXATE. METHOTREXATE 1 Intravenous (not otherwise specified) 10 MG/M2, ONCE/SINGLE ON DAY +7 U 0 10 MG/M**2 CONCENTRATE FOR SOLUTION FOR INJECTION 1X
126280431 12628043 10 SS CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 Unknown 0.5 G, BID U 0 .5 G CAPSULE BID
126280431 12628043 11 SS CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 U 0 CAPSULE
126280431 12628043 12 SS CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 U 0 CAPSULE
126280431 12628043 13 C FLUDARABINE FLUDARABINE PHOSPHATE 1 Intravenous (not otherwise specified) 30 MG/M2, UNK U 0 30 MG/M**2
126280431 12628043 14 C CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) U 0
126280431 12628043 15 C BUSULFAN. BUSULFAN 1 Unknown U 0 TABLET
126280431 12628043 16 C ANTITHYMOCYTE IMMUNOGLOBULIN THYMOCYTE IMMUNE GLOBULIN NOS 1 Intravenous drip 2.5 MG/KG, QD U 0 2.5 MG/KG QD
126280431 12628043 17 C SULFAMETHOXAZOLE SULFAMETHOXAZOLE 1 Unknown 0 TABLET
126280431 12628043 18 C FLUCONAZOLE. FLUCONAZOLE 1 Unknown 0 TABLET
126280431 12628043 19 C ACYCLOVIR. ACYCLOVIR 1 Unknown 0 TABLET
126280431 12628043 20 C ALPROSTADIL. ALPROSTADIL 1 Unknown 0
126280431 12628043 21 C HEPARIN HEPARIN SODIUM 1 Unknown 0
126280431 12628043 22 C URSODEOXYCHOLIC ACID URSODIOL 1 Unknown 0
126280431 12628043 23 C MESNA. MESNA 1 Unknown 0
126280431 12628043 24 C FILGRASTIM FILGRASTIM 1 Unknown 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126280431 12628043 1 Stem cell transplant
126280431 12628043 2 Prophylaxis against graft versus host disease
126280431 12628043 3 Immunosuppressant drug therapy
126280431 12628043 4 Stem cell transplant
126280431 12628043 5 Prophylaxis against graft versus host disease
126280431 12628043 6 Immunosuppressant drug therapy
126280431 12628043 7 Stem cell transplant
126280431 12628043 8 Prophylaxis against graft versus host disease
126280431 12628043 9 Immunosuppressant drug therapy
126280431 12628043 10 Stem cell transplant
126280431 12628043 11 Prophylaxis against graft versus host disease
126280431 12628043 12 Immunosuppressant drug therapy
126280431 12628043 13 Bone marrow conditioning regimen
126280431 12628043 14 Bone marrow conditioning regimen
126280431 12628043 15 Bone marrow conditioning regimen
126280431 12628043 16 Bone marrow conditioning regimen
126280431 12628043 17 Prophylaxis
126280431 12628043 18 Prophylaxis
126280431 12628043 19 Prophylaxis
126280431 12628043 20 Prophylaxis
126280431 12628043 21 Prophylaxis
126280431 12628043 22 Prophylaxis
126280431 12628043 23 Prophylaxis
126280431 12628043 24 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126280431 12628043 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126280431 12628043 Neutropenia
126280431 12628043 Stomatitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found